Earnest Partners LLC Reduces Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Earnest Partners LLC lessened its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 422,453 shares of the medical instruments supplier’s stock after selling 4,933 shares during the period. Earnest Partners LLC owned approximately 0.18% of DENTSPLY SIRONA worth $27,392,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of XRAY. Alps Advisors Inc. boosted its holdings in DENTSPLY SIRONA by 0.3% in the second quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock valued at $488,000 after purchasing an additional 20 shares during the last quarter. Wetherby Asset Management Inc. boosted its holdings in DENTSPLY SIRONA by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock valued at $324,000 after purchasing an additional 30 shares during the last quarter. HighTower Advisors LLC boosted its holdings in DENTSPLY SIRONA by 0.6% in the first quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock valued at $424,000 after purchasing an additional 39 shares during the last quarter. BRYN MAWR TRUST Co boosted its holdings in DENTSPLY SIRONA by 0.5% in the second quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock valued at $782,000 after purchasing an additional 65 shares during the last quarter. Finally, Atria Investments LLC boosted its holdings in DENTSPLY SIRONA by 1.5% in the second quarter. Atria Investments LLC now owns 4,541 shares of the medical instruments supplier’s stock valued at $294,000 after purchasing an additional 68 shares during the last quarter. 93.87% of the stock is owned by institutional investors.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) traded down 0.29% during midday trading on Wednesday, reaching $59.33. The company had a trading volume of 346,829 shares. The stock’s 50 day moving average price is $57.94 and its 200-day moving average price is $61.07. DENTSPLY SIRONA Inc. has a one year low of $52.54 and a one year high of $65.68. The firm’s market capitalization is $13.62 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.65. The firm had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. DENTSPLY SIRONA’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.76 earnings per share. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by BBNS and is owned by of BBNS. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://baseballnewssource.com/markets/earnest-partners-llc-sells-4933-shares-of-dentsply-sirona-inc-xray/1702003.html.

Several analysts have issued reports on XRAY shares. HC Wainwright restated a “buy” rating and set a $68.00 price objective (down previously from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday, August 14th. Credit Suisse Group restated an “outperform” rating and issued a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. Morgan Stanley restated an “overweight” rating and issued a $69.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Friday, October 6th. BidaskClub upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Finally, TheStreet lowered DENTSPLY SIRONA from a “b” rating to a “c+” rating in a report on Wednesday, August 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $65.89.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.